Cargando…

Comment on: update on the management of overactive bladder

Detalles Bibliográficos
Autor principal:	Staskin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785269/ https://www.ncbi.nlm.nih.gov/pubmed/35082922 http://dx.doi.org/10.1177/17562872211070645

Ejemplares similares

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair: reply to comment by Jacquetin
por: Rogowski, A., et al.
Publicado: (2014)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2010)

Update on the management of overactive bladder: patient considerations and adherence
por: Gomelsky, Alex, et al.
Publicado: (2010)

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care
por: Staskin, David R., et al.
Publicado: (2012)

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2014)

Re: Insufficient conclusions regarding the association between overactive bladder symptoms and degree of dementia
por: Kim, Jae Heon
Publicado: (2017)

An Update on the Management of Diabetic Neuropathic Pain: A Few Comments
por: Ghobadifar, Mohamed Amin
Publicado: (2015)

Comment on ‘Outcomes of Asymmetric Primary Inferior Oblique Muscle Overaction Managed by Bilateral Myectomy and Tucking of Proximal Muscle End: A Cohort Study’
por: Chhablani, Preeti Patil
Publicado: (2016)

Comments on: Comparison of three different endoscopic techniques in management of bladder calculi
por: Kamarulzaman, Mohd. Nazli
Publicado: (2011)

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study
por: Staskin, David, et al.
Publicado: (2023)

Comments on: Surgical management of Helveston syndrome (triad of A pattern exotropia, superior oblique overaction, and dissociated vertical deviation) using four oblique procedure
por: Pandey, Pramod K, et al.
Publicado: (2021)

Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study
por: Frankel, Jeffrey, et al.
Publicado: (2021)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Response to comments on: Surgical management of Helveston syndrome (triad of A pattern exotropia, superior oblique overaction and dissociated vertical deviation) using four oblique procedure
por: Agashe, Prachi, et al.
Publicado: (2021)

Response to Comments: Anaesthetic management of a patient with amyotrophic lateral sclerosis for transurethral resection of bladder tumour
por: Thampi, Suma M, et al.
Publicado: (2013)

Update on tolterodine extended-release for treatment of overactive bladder
por: Omotosho, Tola, et al.
Publicado: (2010)

Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR
por: Frankel, Jeffrey, et al.
Publicado: (2021)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023)

Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions
por: Staskin, D R, et al.
Publicado: (2008)

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
por: Periclou, Antonia, et al.
Publicado: (2019)

Comment on “Anaesthetic management of a patient with amyotrophic lateral sclerosis for transurethral resection of bladder tumour”
por: Hobaika, Adriano BS, et al.
Publicado: (2013)

Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Recent advances in management of bladder overactivity
por: Smith, Ariana L, et al.
Publicado: (2010)

Recent advances in managing overactive bladder
por: Araklitis, George, et al.
Publicado: (2020)

RE: Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
por: Abdelwahab, Osama, et al.
Publicado: (2016)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
por: Chandler, Rebecca Ellen, et al.
Publicado: (2018)

Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms
por: Mansfield, Kylie J., et al.
Publicado: (2022)

Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
por: Staskin, David, et al.
Publicado: (2022)

Comment on “Surgically Resected Gall Bladder: Is Histopathology Needed for All?”
por: Barreto, Savio George
Publicado: (2016)

Commentary on “Role of Transcutaneous Electrical Nerve Stimulation in Treating Children With Overactive Bladder From Pooled Analysis of 8 Randomized Controlled Trials”
por: Beloy, Isabel Casal, et al.
Publicado: (2020)

Commentary on “Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016”
por: Tae, Bum Sik, et al.
Publicado: (2021)

RE: Parasacral transcutaneous electrical nerve stimulation in children with overactive bladder: comparison between sessions administered two and three times weekly
por: Lopes, Johnnatas Mikael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tp1ut5qeinmpcicsn976h4ar6l